跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20,534 条关于
“nerve agent exposure”
全部
20,534
临床试验
14,346
药物
731
机构
33
资讯
5,424
去年
Revive Therapeutics Focuses R&D on Bucillamine for Infectious Diseases and Nerve Agent Exposure
10个月前
Revive Therapeutics Advances Bucillamine Research for Nerve Agent Countermeasure in Collaboration with Canadian Defense Agency
6个月前
Revive Therapeutics Expands Bucillamine Patent Portfolio with North American Filings for Chemical Warfare Agent Treatment
去年
FDA Approves Amneal's Extended-Release Pyridostigmine Bromide Tablets for Nerve Agent Pretreatment
3天前
Revive Therapeutics to Expand Bucillamine IP and Orphan Drug Portfolio Across Medical Countermeasures and Rare Diseases
7个月前
Trace Biosciences Receives FDA IND Clearance for First-in-Class Nerve-Specific Imaging Agent LGW16-03
2年前
Revive Therapeutics Advances Bucillamine Development for Long COVID Treatment Through Manufacturing Partnership
去年
Amneal's Pyridostigmine Bromide Extended-Release Tablets Receive FDA Approval for Nerve Agent Pretreatment
去年
Vagus Nerve Stimulation Shows Promise for Treatment-Resistant Depression
去年
Vagus Nerve Stimulation Shows Promise for Rheumatoid Arthritis Treatment
第 1 页,共 543 页
上一页
下一页